Roche wins CE Mark for Accu-Chek Solo insulin micropump

Roche (OTC:RHHBY) said today that it won CE Mark clearance for its Accu-Chek Solo insulin micropump system.
The company plans to launch a pilot commercialization phase for its device in the coming weeks in Austria, Poland, Switzerland and the U.K.
Get the full story at our sister site, Drug Delivery Business News.
The post Roche wins CE Mark for Accu-Chek Solo insulin micropump appeared first on MassDevice.

Source: Mass Device - July 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat Roche Source Type: news